Usefulness of glycosylated haemoglobin (HbA1c) to screen for diabetes in patients with schizophrenia

Schizophrenia Research

Volumn 85, Issue 1-3, 2006, Pages 296-297

  Hanssens, Linda ^a   De Hert, Marc ^b   Van Eyck, Dominique ^b   Wampers, Martien ^b   Scheen, Andre ^a   Peuskens, Joseph ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; NEUROLEPTIC AGENT;

CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFORMED CONSENT; LETTER; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; SCHIZOPHRENIA;

EID: 33745339383     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.03.038     Document Type: Letter

References (10)

1. American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27 (2004) 596-601
2. De Nayer A., De Hert M., Scheen A., et al. Conference report: Belgian consensus on metabolic problems associated with second-generation antipsychotics. Int. J. Psychiatry Clin. Pract. 9 2 (2005) 130-137
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3166
5. Expert Group. 'Schizophrenia and diabetes 2003' expert consensus meeting, Dublin, 3-4 October: consensus summary. Br. J. Psychiatry 47 Suppl. (2004) S112-S114
6. Kilpatrick E.S., Maylor P.W., and Keevil B.G. Biological variations of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 21 (1998) 261-264
7. Mulkerin E.C., Arnold J.D., Dewar, et al. Glycosylated haemoglobin in the diagnosis of diabetes mellitus in elderly people. Age Ageing 21 (1992) 175-177
8. Newcomer J.W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19 Suppl. 1 (2005) 1-93
9. 1c) in screening for undiagnosed diabetes in the US population. Diabetes Care 23 (2000) 187-191
10. Scheen A.J., and De Hert M. Drug-induced diabetes mellitus: the example of atypical antipsychotics. Rev. Med. Liege 60 5-6 (2005) 455-460